Ketamine nasal spray for depression and anxiety in cancer
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether a low dose of ketamine nasal spray can help reduce depression and anxiety in people living with advanced cancer. If you have a progressive cancer and are feeling down or anxious, you might benefit from this quick treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a progressive cancer expected to last at least 2 years
- You need to have some symptoms of depression or anxiety (scored 6 or higher on a simple questionnaire)
- You must be 18 or older and able to attend study visits in person
- You must speak and understand German
- You cannot have serious heart problems, recent suicidal thoughts, or a history of ketamine abuse
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a nasal spray called midazolam to quickly reduce anxiety in people receiving palliative care. If you're an adult in the hospital with sudden anxiety, this could help you feel calmer.
This trial tests whether esketamine, an anesthetic, can help reduce severe depression symptoms in women having breast cancer surgery. You may qualify if you have severe depression before surgery.
This trial tests whether a medicine called esketamine (given during anesthesia) can help reduce anxiety, sadness, or other negative emotions that often occur before and after breast cancer surgery. This could help you feel better emotionally during your recovery.
This trial tests whether giving a medication called esketamine during breast cancer surgery can help reduce negative emotions like depression and anxiety after surgery. It is for women who already have mild to severe depression symptoms.
This trial tests if a ketamine mist you breathe in can help treat moderate to severe depression. It is for adults who are not helped enough by other treatments.
This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.
Hear when a new Depressive Symptoms Mild to Moderate in Severity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.